Neurotrophic Keratopathy Recruiting Phase Trials for Cenegermin (DB13926)
Also known as: Neurotrophic Keratitis / Neurotrophic keratitis (disorder)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0077055 (Neurotrophic Keratopathy) | Recruiting | Not Available |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT04573647 | OCT Evaluation of Neurotrophic Ulcer Following Treatment With Oxervate | ||
| NCT04627571 | Corneal Nerves After Treatment With Cenegermin | ||
| NCT05552261 | DEFENDO Long Term Follow-up Study in Stage 1 NK Patients |